Medical Management of Brain-Dead Organ Donors

키워드

참고문헌 (83)

1. Kutsogiannis DJ, "Medical management to optimize donor organ potential : review of the literature", Can J Anaesth, 53, pp.820~830 (2006)
2. McKeown DW, "Management of the heartbeating brain-dead organ donor", Br J Anaesth, 108(Suppl 1), pp.i96~i107 (2012)
3. Bos EM, "Kidney grafts from brain dead donors: inferior quality or opportunity for improvement?", Kidney Int, 72, pp.797~805 (2007)
4. Rodrigues Sde L, "Profile of effective donors from organ and tissue procurement services", Rev Bras Ter Intensiva, 26, pp.21~27 (2014)
5. Wood KE, "Care of the potential organ donor", N Engl J Med, 351, pp.2730~2739 (2004)
6. Goila AK, "The diagnosis of brain death", Indian J Crit Care Med, 13, pp.7~11 (2009)
7. de Groot YJ, "Imminent brain death : point of departure for potential heart-beating organ donor recognition", Intensive Care Med, 36, pp.1488~1494 (2010)
8. Dhanwate AD, "Brainstem death : a comprehensive review in Indian perspective", Indian J Crit Care Med, 18, pp.596~605 (2014)
9. [URL]
10. Karasawa H, "Intracranial electroencephalographic changes in deep anesthesia", Clin Neurophysiol, 112, pp.25~30 (2001)
11. [URL]
12. Kotloff RM, "Management of the potential organ donor in the ICU : Society of Critical Care Medicine", American College of Chest Physicians, Crit Care Med, pp.2015, 43[DOI]
13. Hahnenkamp K, "Organ-protective intensive care in organ donors", Dtsch Arztebl Int, 113, pp.552~558 (2016)
14. Powner DJ, "Proposed treatment guidelines for donor care", Prog Transplant, 14, pp.16~26 (2004)
15. Smith M, "Physiologic changes during brain stem death: lessons for management of the organ donor", J Heart Lung Transplant, 23(9 Suppl), pp.S217~S222 (2004)
16. Amado JA, "Blood levels of cytokines in brain-dead patients : relationship with circulating hormones and acute-phase reactants", Metabolism, 44, pp.812~816 (1995)
17. Mascia L, "Management to optimize organ procurement in brain dead donors", Minerva Anestesiol, 75, pp.125~133 (2009)
18. Rey JW, "Organ protective intensive care treatment and simulationbased training", Anaesthesist, 61, pp.242~248 (2012)
19. Rech TH, "Management of the brain-dead organ donor : a systematic review and meta-analysis", Transplantation, 95, pp.966~974 (2013)
20. Wong J, "Management of the brain dead organ donor", Trends Anaesth Crit Care, 13, pp.6~12 (2017)
21. Kumar L, "Brain death and care of the organ donor", J Anaesthesiol Clin Pharmacol, 32, pp.146~152 (2016)
22. Szabó G, "Modulation of coronary perfusion pressure can reverse cardiac dysfunction after brain death", Ann Thorac Surg, 67, pp.18~25 (1999)
23. Venkateswaran RV, "Early donor management increases the retrieval rate of lungs for transplantation", Ann Thorac Surg, 85, pp.278~286 (2008)
24. Avlonitis VS, "Pulmonary transplantation : the role of brain death in donor lung injury", Transplantation, 75, pp.1928~1933 (2003)
25. Novitzky D, "Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon", Ann Thorac Surg, 43, pp.288~294 (1987)
26. Strieter RM, "Acute lung injury : the role of cytokines in the elicitation of neutrophils", J Investig Med, 42, pp.640~651 (1994)
27. de Vries DK, "Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation", Am J Transplant, 11, pp.1064~1070 (2011)
28. Bugge JF, "Brain death and its implications for management of the potential organ donor", Acta Anaesthesiol Scand, 53, pp.1239~1250 (2009)
29. Novitzky D, "Hormonal therapy of the brain-dead organ donor : experimental and clinical studies", Transplantation, 82, pp.1396~1401 (2006)
30. Gramm HJ, "Acute endocrine failure after brain death?", Transplantation, 54, pp.851~857 (1992)
31. Howlett TA, "Anterior and posterior pituitary function in brain-stem-dead donors : a possible role for hormonal replacement therapy", Transplantation, 47, pp.828~834 (1989)
32. Tien RD, "Sequence of enhancement of various portions of the pituitary gland on gadolinium-enhanced MR images : correlation with regional blood supply", AJR Am J Roentgenol, 158, pp.651~654 (1992)
33. Blasi-Ibanez A, "Predictors associated with terminal renal function in deceased organ donors in the intensive care unit", Anesthesiology, 110, pp.333~341 (2009)
34. Barklin A, "Systemic inflammation in the brain-dead organ donor", Acta Anaesthesiol Scand, 53, pp.425~435 (2009)
35. Murugan R, "Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation", Crit Care Med, 36, pp.1810~1816 (2008)
36. Pandit RA, "Management of potential organ donor : Indian Society of Critical Care Medicine : position statement", Indian J Crit Care Med, 21, pp.303~316 (2017)
37. Talving P, "Coagulopathy in severe traumatic brain injury : a prospective study", J Trauma, 66, pp.55~61 (2009)
38. Barklin A, "Coagulopathy during induced severe intracranial hypertension in a porcine donor model", Anesthesiology, 110, pp.1287~1292 (2009)
39. (2010)[URL]
40. Gelb AW, "Anaesthetic management of the brain dead for organ donation", Can J Anaesth, 37, pp.806~812 (1990)
41. Franklin GA, "Optimization of donor management goals yields increased organ use", Am Surg, 76, pp.587~594 (2010)
42. Selck FW, "Deceased organ donor characteristics and clinical interventions associated with organ yield", Am J Transplant, 8, pp.965~974 (2008)
43. Klein AS, "Organ donation and utilization in the United States, 1999-2008", Am J Transplant, 10(4 Pt 2), pp.973~986 (2010)
44. Wood KE, "Management of the potential organ donor", Transplant Rev, 21, pp.204~218 (2007)
45. Shemie SD, "Organ donor management in Canada : recommendations of the forum on Medical Management to Optimize Donor Organ Potential", CMAJ, 174, pp.S13~S32 (2006)
46. Nygaard CE, "Organ donor management and organ outcome : a 6-year review from a Level I trauma center", J Trauma, 30, pp.728~732 (1990)
47. Wood KE, "Intensivists and organ donor management", Curr Opin Anaesthesiol, 20, pp.97~99 (2007)
48. Rona G, "Catecholamine cardiotoxicity", J Mol Cell Cardiol, 17, pp.291~306 (1985)
49. Avlonitis VS, "The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor", Am J Transplant, 5(4 Pt 1), pp.684~693 (2005)
50. Plurad DS, "Donor hormone and vasopressor therapy : closing the gap in a transplant organ shortage", J Trauma Acute Care Surg, 73, pp.689~694 (2012)
51. Plurad DS, "Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors", Am J Surg, 204, pp.856~860 (2012)
52. Callahan DS, "The effect of arginine vasopressin on organ donor procurement and lung function", J Surg Res, 186, pp.452~457 (2014)
53. Pennefather SH, "Use of low dose arginine vasopressin to support brain-dead organ donors", Transplantation, 59, pp.58~62 (1995)
54. Chen JM, "Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors", Circulation, 100(19 Suppl), pp.II244~II246 (1999)
55. Di Giantomasso D, "Norepinephrine and vital organ blood flow", Intensive Care Med, 28, pp.1804~1809 (2002)
56. Di Giantomasso D, "Effect of low-dose vasopressin infusion on vital organ blood flow in the conscious normal and septic sheep", Anaesth Intensive Care, 34, pp.427~433 (2006)
57. Weiner N, "Goodman and Gilman’s the pharmacological basis of therapeutics", pp.145~180 (1985), MacMillan
58. Novitzky D, "Haemodynamic changes, myocardial injury, and pulmonary oedema induced by sympathetic activity during the development of brain death in the baboon", Transplant Proc, 13, pp.609~612 (1986)
59. Yoshioka T, "Prolonged hemodynamic maintenance by the combined administration of vasopressin and epinephrine in brain death : a clinical study", Neurosurgery, 18, pp.565~567 (1986)
60. Findlater C, "Organ donation and management of the potential organ donor", Anaesth Intensive Care Med, 16, pp.315~320 (2015)
61. Mi Z, "The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors", Clin Epidemiol, 7, pp.17~27 (2014)
62. Logigian EL, "Terminal electrocardiographic changes in brain-dead patients", Neurology, 35, pp.915~918 (1985)
63. Vaghadia H, "Atropine resistance in brain-dead organ donors", Anesthesiology, 65, pp.711~712 (1986)
64. Mascia L, "Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation : a randomized controlled trial", JAMA, 304, pp.2620~2627 (2010)
65. Rosendale JD, "Aggressive pharmacologic donor management results in more transplanted organs", Transplantation, 75, pp.482~487 (2003)
66. Goarin JP, "The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors", Anesth Analg, 83, pp.41~47 (1996)
67. Novitzky D, "Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy", Transplantation, 45, pp.32~36 (1988)
68. Novitzky D, "Improved cardiac function following hormonal therapy in brain dead pigs : relevance to organ donation", Cryobiology, 24, pp.1~10 (1987)
69. Randell TT, "Triiodothyronine treatment is not indicated in brain-dead multiorgan donors: a controlled study", Transplant Proc, 25(1 Pt 2), pp.1552~1553 (1993)
70. Masson F, "Thyroid function in brain-dead donors", Transpl Int, 3, pp.226~233 (1990)
71. Zaroff JG, "Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va", Circulation, 106, pp.836~841 (2002)
72. Salim A, "The role of thyroid hormone administration in potential organ donors", Arch Surg, 136, pp.1377~1380 (2001)
73. Novitzky D, "Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors", Transplantation, 43, pp.852~854 (1987)
74. Rosendale JD, "Increased transplanted organs from the use of a standardized donor management protocol", Am J Transplant, 2, pp.761~768 (2002)
75. Kotsch K, "Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation : a prospective randomized controlled trial", Ann Surg, 248, pp.1042~1050 (2008)
76. McLean KM, "Glucocorticoids alter the balance between proand anti-inflammatory mediators in the myocardium in a porcine model of brain death", J Heart Lung Transplant, 26, pp.78~84 (2007)
77. Kainz A, "Steroid pretreatment of organ donors to prevent postischemic renal allograft failure : a randomized, controlled trial", Ann Intern Med, 153, pp.222~230 (2010)
78. Chamorro C, "Controversial points in organ donor management", Transplant Proc, 41, pp.3473~3475 (2009)
79. Singer P, "Effect of nutritional state of braindead organ donor on transplantation", Nutrition, 17, pp.948~952 (2001)
80. Singer P, "Brain death and organ damage : the modulating effects of nutrition", Transplantation, 80, pp.1363~1368 (2005)
81. Najafizadeh K, "Age and sex predict PaO2", FiO2 ratio in brain-dead donor lungs, 2009, pp.41, 2720~2722
82. Van Raemdonck D, "Lung donor selection and management", Proc Am Thorac Soc, 6, pp.28~38 (2009)
83. Zafar F, "Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12, 000 lung transplants", J Thorac Cardiovasc Surg, 143, pp.919~925 (2012)

관련 논문AI추천